This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Blair, S. L. Articles by Burt, M. Search for Related Content PubMed PubMed Citation Articles by Blair, S. L. Articles by Burt, M.

Glutathione Metabolism in Patients with Non-Small Cell Lung Cancers

Department of Surgery, Memorial Sloan-Kettering Cancer Center New York, NY 10021 [S. L. B., S. S., A. A., S. H., H. C., M. B.], and Department of Anesthesiology and Critical Care Medicine, Memorial Sloan-Kettering Cancer Center, Department of Anesthesiology, New York Hospital, Cornell Medical Center, New York, NY 10021 [P. H.]

Non-small cell lung cancer (NSCLC) is the leading cause of cancer death in the United States. Because NSCLC is highly chemoresistant, it is usually not treatable. Altered glutathione (GSH) metabolism is thought to be one major mechanism of chemoresistance, and GSH levels are reported to be elevated in NSCLC. The main objective of this study is to delineate the potential mechanisms involved in elevation of tissue GSH, including extraction from the circulation by NSCLC. Twenty consecutive patients with NSCLC were enrolled. At the time of lobectomy, pulmonary artery and vein were identified, and blood flow was measured by an electromagnetic probe. Subsequently, blood samples were drawn from pulmonary artery, the vein draining the tumor-bearing lobe, and a normal lobe. Immediately after lobectomy, tumor and lung specimens were snap frozen. NSCLC tumor specimens had higher levels of GSH compared with lung tissue (20.8 ± 9.4 versus 11.6 ± 3.0 nmol/mg protein, respectively; P < 0.05). The tumor demonstrated higher activity of the enzyme -glutamyl transpeptidase, a membrane-bound enzyme involved in transmembrane uptake of GSH, than lung tissue (41.9 ± 26.4 versus 22.4 ± 12.3 units/mg protein, respectivel; P < 0.05). Also, the tumor-bearing lobe showed elevated extraction of GSH and two of its component amino acids compared with lung tissue (GSH uptake: 0.60 ± 0.67 versus 0.20 ± 0.40 µM/min, respectively; P < 0.05). NSCLC tumors are able to extract circulating GSH and its constituent amino acids to synthesize intracellular GSH. Increased activity of -glutamyl transpeptidase may be one mechanism underlying increased GSH uptake by NSCLC.

¹ To whom requests for reprints should be addressed, at Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021. Phone: (212) 639-8026; Fax: (212) 717-3124.

Received 6/20/96. Accepted 10/31/96.

This article has been cited by other articles:

				P. E. Thelwall, A. Y. Yemin, T. L. Gillian, N. E. Simpson, M. S. Kasibhatla, Z. N. Rabbani, J. M. Macdonald, S. J. Blackband, and M. P. Gamcsik Noninvasive In vivo Detection of Glutathione Metabolism in Tumors Cancer Res., November 15, 2005; 65(22): 10149 - 10153. [Abstract] [Full Text] [PDF]

				S. Gunnarsdottir, M. Rucki, and A. A. Elfarra Novel Glutathione-Dependent Thiopurine Prodrugs: Evidence for Enhanced Cytotoxicity in Tumor Cells and for Decreased Bone Marrow Toxicity in Mice J. Pharmacol. Exp. Ther., April 1, 2002; 301(1): 77 - 86. [Abstract] [Full Text] [PDF]

				E Maellaro, S Dominici, B Del Bello, M. Valentini, L Pieri, P Perego, R Supino, F Zunino, E Lorenzini, A Paolicchi, et al. Membrane gamma-glutamyl transpeptidase activity of melanoma cells: effects on cellular H(2)O(2) production, cell surface protein thiol oxidation and NF-kappa B activation status J. Cell Sci., January 8, 2000; 113(15): 2671 - 2678. [Abstract] [PDF]

				I. Rahman and W. MacNee Lung glutathione and oxidative stress: implications in cigarette smoke-induced airway disease Am J Physiol Lung Cell Mol Physiol, December 1, 1999; 277(6): L1067 - L1088. [Abstract] [Full Text] [PDF]